Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Paul A. DiSilvestro"'
Autor:
Nicole E. James, Jenna B. Emerson, Ashley D. Borgstadt, Lindsey Beffa, Matthew T. Oliver, Virginia Hovanesian, Anze Urh, Rakesh K. Singh, Rachael Rowswell-Turner, Paul A. DiSilvestro, Joyce Ou, Richard G. Moore, Jennifer R. Ribeiro
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-12 (2020)
Abstract Epithelial ovarian cancer (EOC) is a highly lethal gynecologic malignancy arising from the fallopian tubes that has a high rate of chemoresistant recurrence and low five-year survival rate. The ovarian cancer biomarker HE4 is known to promot
Externí odkaz:
https://doaj.org/article/1e2034decd7b4213a5c0a5824478d5c9
Autor:
Amita Kulkarni, Adrian Chiem, Kamaljeet Singh, Cara Mathews, Paul A. DiSilvestro, Lindsey Beffa
Publikováno v:
Gynecologic Oncology Reports, Vol 37, Iss , Pp 100856- (2021)
Externí odkaz:
https://doaj.org/article/03d246577b7f47039dcb8ba763bb8f59
Autor:
Nicole E. James, Matthew T. Oliver, Jennifer R. Ribeiro, Evelyn Cantillo, Rachael B. Rowswell-Turner, Kyu-Kwang Kim, Clinton O. Chichester, Paul A. DiSilvestro, Richard G. Moore, Rakesh K. Singh, Naohiro Yano, Ting C. Zhao
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
While selective overexpression of serum clinical biomarker Human epididymis secretory protein 4 (HE4) is indicative of ovarian cancer tumorigenesis, much is still known about the mechanistic role of the HE4 gene or gene product. Here, we examine the
Externí odkaz:
https://doaj.org/article/1d40d022ef174c3eb530873e0bececed
Autor:
Jennifer R. Ribeiro, Hilary M. Gaudet, Mehreen Khan, Christoph Schorl, Nicole E. James, Matthew T. Oliver, Paul A. DiSilvestro, Richard G. Moore, Naohiro Yano
Publikováno v:
Frontiers in Oncology, Vol 7 (2018)
Human epididymis protein 4 (HE4) has received much attention recently due to its diagnostic and prognostic abilities for epithelial ovarian cancer. Since its inclusion in the Risk of Ovarian Malignancy Algorithm (ROMA), studies have focused on its fu
Externí odkaz:
https://doaj.org/article/35ddc51ef9b84832a570f414c883d609
Autor:
Matthew A. Powell, Virginia L. Filiaci, Martee L. Hensley, Helen Q. Huang, Kathleen N. Moore, Krishnansu S. Tewari, Larry J. Copeland, Angeles A. Secord, David G. Mutch, Alessandro Santin, David P. Warshal, Nick M. Spirtos, Paul A. DiSilvestro, Olga B. Ioffe, David S. Miller
Publikováno v:
J Clin Oncol
PURPOSE This phase III randomized trial ( NCT00954174 ) tested the null hypothesis that paclitaxel and carboplatin (PC) is inferior to paclitaxel and ifosfamide (PI) for treating uterine carcinosarcoma (UCS). PATIENTS AND METHODS Adults with chemothe
Autor:
Floor J. Backes, Lindsey B. Beffa, Caroline C. Billingsley, Michael J. Birrer, Kristin Bixel, Teresa K.L. Boitano, Wendy R. Brewster, Dana M. Chase, Shaina Bruce, Angelena Crown, Christina S. Chu, Daniel L. Clarke-Pearson, Robert A. Ross, Brian Crosland, Joshua G. Cohen, Robert L. Coleman, Paul A. DiSilvestro, Oliver Dorigo, Linda R. Duska, Ramez Nassef Eskander, Mary L. Gemignani, Camille Catherine Gunderson, Andrea R. Hagemann, Thomas J. Herzog, Travis R. Korenaga, Warner K. Huh, Lindsay Kuroki, Katherine Kurnit, Robert S. Mannel, L. Stewart Massad, Cara A. Mathews, David S. Miller, Bradley J. Monk, David G. Mutch, Rachita Nikam, JoAnn V. Pinkerton, Matthew Powell, Dominique L. Rash, Lisa M. Landrum, Kari L. Ring, Malte Renz, Brandon Roane, Stephen C. Rubin, Ritu Salani, Jane Satero, Anil K. Sood, John T. Soper, Elizabeth Christina Stock, C. James Sung, Krishnansu Sujata Tewari, Michael D. Toboni, Katherine Tucker, Joan L. Walker, Jaclyn A. Wall, Christina Washington, Lari B. Wenzel, Shannon N. Westin, Catheryn M. Yashar, William T. Creasman, Rosemary E. Zuna
Publikováno v:
DiSaia and Creasman Clinical Gynecologic Oncology ISBN: 9780323776844
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59f2af7fb1962f9f8ad8f72cfeaa7346
https://doi.org/10.1016/b978-0-323-77684-4.00003-9
https://doi.org/10.1016/b978-0-323-77684-4.00003-9
Publikováno v:
DiSaia and Creasman Clinical Gynecologic Oncology ISBN: 9780323776844
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efef5fb2b502ed1c9df6eab3f9a63936
https://doi.org/10.1016/b978-0-323-77684-4.00019-2
https://doi.org/10.1016/b978-0-323-77684-4.00019-2
Autor:
Ursula A. Matulonis, Helen Q. Huang, Virginia L. Filiaci, Marcus Randall, Paul A. DiSilvestro, Katherine M. Moxley, Jeffrey M. Fowler, Matthew A. Powell, Nick M. Spirtos, Krishnansu S. Tewari, William E. Richards, John M. Nakayama, David G. Mutch, David S. Miller, Daniela Matei, Lari B. Wenzel
Publikováno v:
Gynecol Oncol
INTRODUCTION: Chemotherapy plus radiation (Cis-RT+CP) did not demonstrate superiority in prolonging relapse-free survival compared to chemotherapy alone in patients with stage III or IVA endometrial carcinoma. The impact of treatment on quality of li
Publikováno v:
Obstetrics and Gynaecology Cases - Reviews. 2
Background: Cervical rhabdomyosarcoma is very rare, comprising less than 1% of cervical cancers in adult women. Less than 40 cases of cervical rhabdomyosarcoma have been reported in adult women in the last 50 years. Due to the rarity of this disease,
Publikováno v:
Obstetrics & Gynecology. 100:724-729